Diagnosis and management of the erythropoietic porphyrias

Dermatologic Therapy

Volumn 16, Issue 1, 2003, Pages 57-64

  Murphy, Gillian M ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Congenital erythropoietic porphyria; Erythropoietic protoporphyria; Porphyria

Indexed keywords

ACETYLCYSTEINE; ACTIVATED CARBON; ANTIHISTAMINIC AGENT; BETA CAROTENE; COLESTYRAMINE; CYSTEINE; PORPHYRIN; PROTOPORPHYRIN; SUNSCREEN;

ANEMIA; BIOSYNTHESIS; BONE MARROW TRANSPLANTATION; CLINICAL FEATURE; CONGENITAL ERYTHROPOIETIC PORPHYRIA; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; ERYTHEMA; ERYTHROPOIETIC PROTOPORPHYRIA; FLUORESCENCE MICROSCOPY; GALLSTONE; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER DISEASE; LIVER FAILURE; PAIN; PHOTODERMATOSIS; PORPHYRIA; PURPURA; RADIATION EXPOSURE; REVIEW; SOLAR RADIATION; SPLENECTOMY; TREATMENT INDICATION;

HEME; HUMANS; IMMUNOHISTOCHEMISTRY; PORPHYRIA, ERYTHROPOIETIC; ULTRAVIOLET THERAPY;

EID: 0037948285     PISSN: 13960296     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1529-8019.2003.01609.x     Document Type: Review

References (43)

1. Elder GH. The cutaneous porphyrias. In: Hawk JLM, ed. Photodermatology. London: Arnold, 1999: 171-197.
2. Magnus IA, Jarrett A, Prankerd TAJ, et al. Erythropoietic protoporphyria: a new porphyrin syndrome with solar urticaria due to protoporphyrinaemia. Lancet 1961: 2: 448-451.
3. Dean G. The porphyrias. London: Pitman Medical, 1971.
4. Leone N, Marzano A, Cerutti E, et al. Liver transplantation for erythropoietic protoporphyria: report of a case with medium term follow-up. Dig Liver Dis 2000: 32: 799-802.
5. Mendez M, Rossetti MV, De Siervi A, et al. Mutations in familial porphyria cutanea tarda: two novel and two previously described for hepatoerythropoietic porphyria. Hum Mutat 2000: 16: 269-270.
6. Murphy GM, Hawk JLM, Corbett MF, Magnus IA. The UK erythropoietic protoporphyria register. Br J Dermatol 1985: 113 (suppl 29): 11.
7. Carithers RL. Follow up after liver transplantation for protoporphyric liver disease. Liver Transplant Surg 1996: 2: 269-275.
8. Mion FB, Faure JL, Berger F, et al. Liver transplantation for erythropoietic protoporphyria. Report of a new case with subsequent medium-term follow-up. J Hepatol 1992: 16: 203-207.
9. Bonkowsky HL, Schned AR. Fatal liver failure in protoporphyria. Synergism between ethanol excess and the genetic defect. Gastroenterology 1986: 90: 191-201.
10. McCullough AJ, Barron D, Mullen KD, et al. Fecal protoporphyrin excretion in erythropoietic protoporphyria: effect of cholestyramine and bile acid feeding. Gastroenterology 1988: 94: 177-181.
11. Rademakers LH, Koningsberger JC, Sorber CW, Bart de la Faille H, Van-hattum J, Marx JJ. Accumulation of iron in erythroblasts of patients with erythropoietic protoporphyria. eur j clin invest 1993: 23: 130-138.
12. Meerman L, Verwer R, Slooff MJ, et al. Perioperative measures during liver transplantation for erythropoietic protoporphyria. Transplantation 1994: 57: 155-158.
13. Murphy GM, Hawk JLM, Nicholson DC, et al. Congenital erythropoietic porphyria (Gunther's disease) Clin Exp Dermatol 1987: 12: 61-65.
14. MacDonald A, Nicholson D, Williams R. Late onset erythropoietic uroporphyria. Br J Dermatol 1976: 95(Suppl 14): S30-S33.
15. Murphy A, Gibson G, Elder GH, Otridge BA, Murphy GM. Adult-onset congenital erythropoietic porphyria (Gunther's disease) presenting with thrombocytopenia. J R Soc Med 1995: 88: 357-358.
16. Murphy GM, Hawk JL, Magnus IA. Late-onset erythropoietic protoporphyria with unusual cutaneous features. Arch Dermatol 1985: 121: 1309-1312.
17. Casson SE, Elder G, Thomas MA. A plasma porphyrin external quality assurance scheme [abstract]. Proc ACB Natl Meet 1998: 108.
18. Gibbs NK, Traynor N, Ferguson J. Biochemical diagnosis of the cutaneous porphyrias: five years experience of plasma spectro-fluorimetry. Br J Dermatol 1995: 133: S18.
19. Murphy GM. The cutaneous porphyrias. A review of diagnosis and management. JEADV 1993: 2: 11-17.
20. Sandberg S, Romslo I. Porphyrin-induced photodamage at the cellular and the subcellular level as related to the solubility of the porphyrin. Clin Chim Acta 1981: 109: 193-201.
21. Lim H, Cooper D, Sassa S, Dosik H, Buchness MR, Soter N. Photo-sensitivity abnormal porphyrin profile and sideroblastic anaemia. J Am Acad Dermatol 1992: 27(2 pt 2): 287-292.
22. Went LN, Klasen EC. Genetic aspects of erythropoietic protoporphyria. Ann Hum Genet 1984: 48: 105-117.
23. Nunn AVW, Norris P, Hawk JLM, Cox TM. Zinc chelatase in human lymphocytes: detection of the enzymatic defect in erythropoietic protoporphyria. Ann Biochem 1988: 174: 146-150.
24. Sarkany RPE, Alexander GJMA, Cox TM. Recessive inheritance of erythropoietic protoporphyria with liver failure. Lancet 1994: 343: 1394-1396.
25. Gouya L, Deybach JC, Lamoril J, et al. Modulation of the phenotype in dominant erythropoietic protoporphyria by a low expression of the normal ferrochelatase allele. Am J Hum Genet 1996: 58: 292-299.
26. Whitcombe DM, Carter NP, Albertson DG, et al. Assignment of the human ferrochelatase gene (FECH) and a locus for protoporphyria to chromosome 18q22. Genomics 1991: 11: 1152-1154.
27. Gouya L, Puy H, Lamoril J, Da Silva V, et al. Inheritance in erythropoietic protoporphyria: a common wild type ferrochelatase allelic variant with low expression accounts for clinical manifestation. Blood 1999: 6: 2105-2110.
28. Schneider-Yin X, Gouya L, Maier-Weinand A, Deybach JC, Minder EI. New insights into the pathogenesis of erythropoietic protoporphyria and their impact on patient care. Eur J Paediatr 2000: 159: 719-725.
29. Bloomer J, Bruzzone C, Zhu L, et al. Molecular defects in patients with protoporphyria requiringliver transplantation. J Clin Invest 1998: 102: 107-114.
30. Shirota T, Yamamoto H, Hayashi S, et al. Myelodysplastic syndrome terminating in erythropoietic protoporphyria after 15 years of aplastic anaemia. Int J Haematol 2000: 72: 44-47.
31. Ged C, Moreau-Gaudry F, Taine L, et al. Prenatal diagnosis in congenital erythropoietic porphyria by metabolic measurement and DNA mutation analysis. Prenat Diagn 1996: 16: 83-86.
32. Astrin KH, Warner CA, Yoo HW, et al. Regional assignment of the human uroporphyrinogen III synthase (URO-S) gene to chromosome 10q25.2-Q26.3. Hum Genet 1991: 87: 18-22.
33. Xu W, Warner CA, Desnick RJ. Congenital erythropoietic porphyria: identification and expression of 10 mutations in the uroporphyrinogen III synthase gene. J Clin Invest 1995: 95: 905-912.
34. De Leo VA, Poh-Fitzpatrick MB, Matthews-Roth MM, et al. Erythropoietic protoporphyria: ten years of experience. Am J Med 1976: 60: 8-22.
35. Norris PG, Baker CS, Roberts JE, Hawk JL. Treatment of erythropoietic protoporphyria with N-acetylcysteine. Arch Dermatol 1995: 131: 354-355.
36. Mathews-Roth MM, Kosner B, Renfell K, Roberts JK. A double-blind study of cysteine photoprotection in erythropoietic protoporphyria. Photoderm Photoimmunol Photomed 1994: 10: 244-248.
37. Farr PM, Diffey BL, Matthew N. Inhibition of photosensitivity in erythropoietic protoporphyria with terfenadine. Br J Dermatol 1990: 122: 809-815.
38. Collins P, Ferguson J. Narrow band UVB (TL-O1) phototherapy: an effective preventative treatment for the photodermatoses. Br J Dermatol 1995: 132: 965-963.
39. Herbert A, Corbin D, Williams A, et al. Erythropoietic protoporphyria: unusual skin and neurological problems after liver transplantation. Gastoenterol 1991: 100: 1753-1757.
40. Tishler PV, Winston SH. Rapid improvement in the chemical pathology of congenital erythropoietic protoporphyria with treatment with super activated charcoal. Meth Find Exp Clin Pharmacol 1990: 12: 645-648.
41. Harada FA, Shwayder TA, Desnick RJ, Lim HW. Treatment of severe congenital erythropoietic porphyria by bone marrow transplantation. J Am Acad Dermatol 2001: 45: 279-282.
42. Kauffman L, Evans DIK, Stevens RF, Weinkove C. Bone marrow transplantation for congenital erythropoietic porphyria. Lancet 1991: 337: 1510-1511.
43. Lim HW, Murphy GM The porphyrias. Clin Dermatol 1996: 14: 1-13.